Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5847 Journals

4878 Congresses

10700+ Unique Records

ESMO Rare Cancers

Title Abbreviation

ESMO Rare Cancers

Electronic ISSN

3050-4619

Therapeutic Area

Diagnostic Imaging, Diagnostics/Diagnostic Testing, Epidemiology, Genetics, Genomics, Health Policy, Hematology, Molecular Biology, Molecular Medicine, Multidisciplinary Science, Oncology, Pathology, Patient Advocacy, Pediatrics, Precision Medicine, Prevention Research, Rare Diseases, Research, Surgery

Readership

Allied Health Professionals, Clinical Researchers, Diagnosticians, Epidemiologists, Geneticists, Health Professionals, Health Service Researchers, Hematologists, Molecular Biologists, Oncologists, Pathologists, Patient Advocates, Patients, Pediatricians, Prevention Scientists, Radiation Oncologists, Radiologic Technicians, Radiologists, Researchers, Scientists, Scientists - Research/Biomedical Aging, Surgeons, Surgical Oncologists

Scope

ESMO Rare Cancers is a peer-reviewed, open-access medical journal dedicated to advancing the understanding and management of rare cancers. Our mission is to serve as a platform for the dissemination of high-quality research, clinical experiences, and multidisciplinary discussions aimed at improving the diagnosis, treatment, and overall outcomes of patients with rare and understudied malignancies. Rare Cancers encompass a wide spectrum of malignancies characterized by a low incidence rate. These cancers pose unique challenges due to their limited prevalence, leading to gaps in knowledge, diagnosis, and therapeutic strategies. The journal focuses on diseases with an incidence of less than 6 cases per 100,000 individuals per year, defined by histology, molecular hallmarks or other criteria. Solid cancers, haematological malignancies, of children and adults are considered for publication. ESMO Rare Cancers welcomes submissions across various domains, including but not limited to: Epidemiology and Surveillance: Investigations into the incidence, prevalence, and risk factors associated with rare cancers; Diagnostic Advancements: Novel approaches and technologies for early detection and accurate diagnosis; Treatment Modalities: Clinical trials, therapeutic innovations, and management strategies specific to rare cancer types; Patient Care and Quality of Life: Studies addressing supportive care, survivorship, and psychosocial aspects of rare cancer patients; Biomarkers and Precision Medicine: Identification of biomarkers and personalized treatment approaches; Genomics and Pathogenesis: Research on the genetic basis and molecular mechanisms underlying rare cancers; Multidisciplinary Collaboration: We encourage contributions from diverse healthcare professionals, including oncologists, pathologists, radiologists, surgeons, epidemiologists, and allied healthcare experts. Collaborative research, which combines various disciplines, is essential for a comprehensive understanding of rare cancers and the development of effective treatment strategies; Clinical Case Reports: The journal provides a platform for the publication of clinical case reports that offer valuable insights into rare cancer cases, unique diagnostic dilemmas, and innovative treatment approaches; Patient-Centred Focus: Recognizing the significance of the patient perspective, we promote the submission of articles that share patient experiences, challenges, and advocacy efforts, emphasizing the importance of patient-centred care in the rare cancer community.

Sponsoring Association(s)

European Society for Medical Oncology (ESMO)

Publisher Name

Elsevier Ltd. - London

To see more details about ESMO Rare Cancers, Subscribe Now!

Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
	– Kait G Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
	– Michael K. Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
	- Weill Cornell Medical Library

Journals ● Congresses ● Associations

Privacy Policy ● Terms of Service ● Glossary ● Contact Us